Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy Subjects

NCT02256774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BILR 355 BS
DRUG: Combivir®
DRUG: Ritonavir

Sponsor

Boehringer Ingelheim